SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-034606
Filing Date
2011-04-11
Accepted
2011-04-11 16:07:56
Documents
6
Period of Report
2011-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c14941e8vk.htm 8-K 31139
2 EXHIBIT 2.1 c14941exv2w1.htm EX-2.1 505136
3 EXHIBIT 10.1 c14941exv10w1.htm EX-10.1 67295
4 EXHIBIT 10.2 c14941exv10w2.htm EX-10.2 104348
5 EXHIBIT 99.1 c14941exv99w1.htm EX-99.1 9234
6 GRAPHIC c14941p1494101.jpg GRAPHIC 17160
  Complete submission text file 0000950123-11-034606.txt   742481
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
ADVENTRX PHARMACEUTICALS INC (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 11752769
SIC: 2834 Pharmaceutical Preparations